Literature DB >> 3866054

Antibiotic susceptibilities of periodontal bacteria. In vitro susceptibilities to eight antimicrobial agents.

C B Walker, J D Pappas, K Z Tyler, S Cohen, J M Gordon.   

Abstract

In vitro susceptibilities of 369 to 966 bacterial isolates from periodontal lesions to eight antibiotics were determined by agar dilution technique as a means of determining which antimicrobial agents were inhibitory for bacteria frequently associated with destructive periodontal diseases. Although most bacteria were relatively susceptible to the penicillins, greater activity was generally noted with amoxicillin than with either penicillin or ampicillin with the exception of Selenomonas sputigena and Peptostreptococcus. Antibacterial activities obtained with minocycline were significantly higher than with tetracycline for Actinobacillus actinomycetemcomitans and Streptococcus but comparable for most other taxa. Clindamycin and metronidazole both demonstrated excellent activity against the anaerobic Gram-negative rods but were less effective against some of the capnophilic and facultative organisms. Eikenella corrodens was exceptionally resistant to both of these drugs; and A. actinomycetemcomitans was generally resistant to clindamycin but relatively susceptible to metronidazole. Erythromycin was considerably less active than the other antibiotics against the majority of the periodontal bacteria. No single antibiotic, at concentrations equivalent to those achieved in body fluids, was uniformly effective in inhibiting all bacteria currently implicated or suspected as etiologic agents of periodontal diseases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3866054     DOI: 10.1902/jop.1985.56.11s.67

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  15 in total

1.  Effect of ciprofloxacin on killing of Actinobacillus actinomycetemcomitans by polymorphonuclear leukocytes.

Authors:  David A Cacchillo; John D Walters
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

2.  Characterization of minocycline transport by human neutrophils.

Authors:  John D Walters
Journal:  J Periodontol       Date:  2006-12       Impact factor: 6.993

3.  Synergistic effects between amoxicillin, metronidazole, and the hydroxymetabolite of metronidazole against Actinobacillus actinomycetemcomitans.

Authors:  M J Pavicić; A J van Winkelhoff; J de Graaff
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

4.  Periodontal Disease Part III: Chemotherapeutics.

Authors:  E Freeman
Journal:  Can Fam Physician       Date:  1988-06       Impact factor: 3.275

5.  An in vitro model of ciprofloxacin and minocycline transport by oral epithelial cells.

Authors:  James J Brayton; Qing Yang; Robin J Nakkula; John D Walters
Journal:  J Periodontol       Date:  2002-11       Impact factor: 6.993

6.  Heterogeneity of Actinobacillus actinomycetemcomitans strains in various human infections and relationships between serotype, genotype, and antimicrobial susceptibility.

Authors:  S Paju; P Carlson; H Jousimies-Somer; S Asikainen
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

7.  Effect of Exposure to Portland Cement Dust on the Periodontal Status and on the Outcome of Non-Surgical Periodontal Therapy.

Authors:  Alaa Abdelhamid
Journal:  Int J Health Sci (Qassim)       Date:  2016-07

8.  Identification of a streptomycin resistance gene and a partial Tn3 transposon coding for a beta-lactamase in a periodontal strain of Eikenella corrodens.

Authors:  J M Lacroix; C B Walker
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

9.  Characterization of a beta-lactamase found in Eikenella corrodens.

Authors:  J M Lacroix; C Walker
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

10.  Subantimicrobial dose doxycycline effects on osteopenic bone loss: microbiologic results.

Authors:  Clay Walker; Susan Puumala; Lorne M Golub; Julie A Stoner; Richard A Reinhardt; Hsi-Ming Lee; Jeffrey B Payne
Journal:  J Periodontol       Date:  2007-08       Impact factor: 6.993

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.